July, 2025
July 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
28293031  
Oscar Tahuahua: Rational combos and next-gen RAS inhibitors are key
May 4, 2025, 02:34

Oscar Tahuahua: Rational combos and next-gen RAS inhibitors are key

Oscar Tahuahua, Medical Oncology fellow at the National Cancer Institute of Mexico, shared on X about a recent paper by Richard Y. Ebright et al. published in Cancer Discovery:

“RAS Inhibition: Response and Resistance
– Primary (10–20%): KEAP1, PI3K, TP53, SMARCA4 mutations.
– Acquired (~60%): KRAS muts (25–30%), RTKs (20–25%), PI3K (10–15%), MYC, EMT and MAPK pathway.
Rational combos and next-gen RAS inhibitors are key.”

Oscar Tahuahua

Response and Resistance to RAS Inhibition in Cancer

Authors: Richard Y. Ebright et al

Oscar Tahuahua

Learn more about RAS pathway in cancer on OncoDaily.